<DOC>
	<DOCNO>NCT00862433</DOCNO>
	<brief_summary>Background : - Vitamin E antioxidant reduces damage effect oxygen body . Most American men ( 90 % ) woman ( 96 % ) get enough vitamin E diet ; however , amount vitamin E need body study men , woman . In addition , unknown whether another antioxidant , vitamin C , help vitamin E protect body . Because vitamin E fat-soluble vitamin , much body fat person could affect amount vitamin E need protection . Objectives : This study three arm examine vitamin E requirement : - To determine amount fat require get best vitamin E absorption meal . - To determine amount ( i.e. , best dose ) vitamin E must consume measured blood . - To examine vitamin E vitamin C work together body , conjunction diet vitamin supplement . Eligibility : - Arms 1 2 : Women age 18 40 year normal weight body mass index ( BMI ) 27 less . - Arm 3 : Women age 18 40 year normal weight ( BMI 27 ) , overweight ( BMI &gt; 27 ) , overweight ( BMI &gt; 27 ) non insulin-dependent diabetes . Design : - Arm 1 : Five study , last 1 month 1 month study ( total study = 10 month ) . Participants take 500 1,000 mg vitamin C twice daily 2 week admission clinical center 1 week . - Study 1 : Participants eat breakfast contain know amount fat , take vitamin E pill well receive IV injection vitamin E. Other food contain negligible amount vitamin E. Blood urine sample measure level vitamin E substance . - Studies 2 5 : Outpatient visit consist test Study 1 ; however , amount fat breakfast range 0 % 40 % random order . During one study , adipose tissue biopsy collect determine much vitamin E tissue . - Arm 2 : Five study , last 1 month 1 month study ( total study = 10 month ) . Preparation Arm 2 Arm 1 . The proportion fat , muscle , water body also measure . - Study 1 : Participants eat breakfast contain 30 % fat , take vitamin E pill well receive IV injection vitamin E. Conditions procedures Arm 1 . - Studies 2 5 : Outpatient visit consist test Study 1 ; however , amount vitamin E breakfast range 2 30 mg random order . - Arm 3 : Outpatient ( 2 6 week ) inpatient study ( 4 6 week ) . - Outpatient study : Participants take 500 1,000 mg vitamin C daily provide blood urine sample , well adipose tissue sample . - Inpatient study : Two vitamin E inpatient study . Before begin , participant vitamin C blood level reduce mean diet low vitamin C. Blood test determine quickly vitamin C leave body . Once vitamin C level reduce , first vitamin E study begin . Study A : The procedure study Arm 2 , Study 1 . Study B : The procedure study Study A , except participant blood vitamin C level higher .</brief_summary>
	<brief_title>Vitamin E Pharmacokinetics Biomarkers Normal Obese Women</brief_title>
	<detailed_description>Vitamin E ( a-tocopherol ) essential human determine human dietary requirement prove difficult . The recommended dietary allowance ( RDA ) vitamin E meet 96 % American woman , without apparent harm . Because vitamin E antioxidant , optimum consumption vitamin E may improve health obese woman experience high level inflammation oxidative stress . We hypothesize vitamin E function antioxidant related tissue store , delivery tissue store calculate plasma vitamin E turnover kinetics slow release pool . We propose turnover kinetics new mean estimate vitamin E recommend dietary allowance . We study vitamin E pharmacokinetics use dual stable-isotope label ( deuterium ) a-tocopherols administer orally intravenously healthy nonobese , overweight overweight non-insulin require diabetic woman . Blood sample collect interval vitamin E measure mass spectrometry . Because ascorbic acid ( vitamin C ) concentration may alter a-tocopherol pharmacokinetics , subject study first low high steady state plasma vitamin C concentration . Before main study , two preliminary trial perform . In preliminary trial 1 , fat content optimal absorption assess fat-content meal may alter vitamin E absorption . The fat content 0 - 40 % calorie breakfast meal vitamin E administer . In preliminary trial 2 , optimal fat content preliminary trial 1 use , vitamin E dose vary . Vitamin E dose amount could non-specifically alter vitamin E kinetics . We therefore determine large dose ( 2-30 mg ) non-specifically increase vitamin E turnover , fat hold constant . Additionally , measure vitamin E pharmacokinetics function lipid peroxidation biomarkers provide direct data use predict vitamin E requirement woman , set new recommendation vitamin E intake . We explore new a-tocopherol function , specifically whether gene transcription human subject regulate vitamin E status relation vitamin C status . Because vitamin E turnover may affect vitamin C concentration , use vitamin C depletion-repletion study design investigate relationship vitamin C status vitamin E turnover .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<criteria>INCLUSION CRITERIA : Subjects recruit study : Healthy woman Ages 18 40 year old Able give inform consent Blood pressure &lt; 160/90 mm Hg Nonobese ( BMI le equal 29.9 ) without diabetes Overweight ( BMI great equal 27 ) without diabetes Overweight ( BMI great equal 27 ) mild moderate noninsulin dependent diabetes ( Type 2 diabetes ) treat diet alone submaximal dos oral hypoglycemic agent whose fast blood sugar &lt; 200mg/dl HbA1C &lt; 7.5 know target organ damage ( End organ damage include following : proliferative retinopathy , serum creatinine &lt; 1.8 m/dl , ischemic heart disease , congestive heart failure , peripheral vascular disease peripheral neuropathy ) No regular medication aspirin ( oral hypoglycemic agent , hormonal contraceptive medication take asneeded basis ) . Willingness use effective contraceptive method duration study EXCLUSION CRITERIA : Subjects follow disease abnormality eligible study : Digestive abnormality , malabsorption chronic diarrhea Organ malfunction , include ( limited ) liver disease , pulmonary disease , ischemic heart disease , heart failure , stroke , peripheral vascular disease Hypertension ( blood pressure &gt; 160/90 ) Anemia ( hematocrit &lt; 30 ) Current history serious chronic illness , include hyperlipidemia hypercholesterolemia Complications diabetes kidney damage ( renal insufficiency , serum creatinine &gt; 1.8 ) , eye damage ( proliferative retinopathy ) , diabetic neuropathy , coronary artery disease , peripheral vascular disease Tobacco smoking Use medication ( oral hypoglycemic agent , hormonal contraceptive medication take asneeded basis ) . Alcohol drug abuse Insulin treatment Pregnancy lactation ( urine pregnancy test perform woman reproductive age part study monthly necessary ) Positive HIV hepatitis ( b c ) screening test Food allergy , soy egg , milk protein ( casein ) , wheat/gluten Known coagulopathy Unwillingness use effective contraceptive method barrier method duration study . Patients antihypertensive medication exclude even blood pressure well control antihypertensive medication may affect vitamin E status , thus introduce confound variable . Whether antihypertensive medication interacts vitamin E know . Patients insulin treatment exclude Insulin treatment indicate severe form diabetes mild moderate type two diabetes need dietary treatment treatment submaximal dose oral hypoglycemic agent adequate blood sugar control . The effect insulin administration vitamin E unknown , confound factor make data interpretation difficult .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 7, 2016</verification_date>
	<keyword>Vitamin C</keyword>
	<keyword>Antioxidant</keyword>
	<keyword>Lipid Peroxidation</keyword>
	<keyword>Non-Insulin Requiring Diabetics</keyword>
	<keyword>Alpha-Tocopherol</keyword>
	<keyword>Health Volunteer</keyword>
	<keyword>HV</keyword>
	<keyword>Normal Weight</keyword>
	<keyword>Overweight</keyword>
	<keyword>Type 2 Diabetes</keyword>
</DOC>